Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Compressive syndrome of internal jugular veins in multiple sclerosis: does it matter?
MR Imaging in Multiple Sclerosis: The Accuracy of 3D Double Inversion Recovery at 3 Tesla and the Potential for Single Sequence Imaging.
Biochemical and antiviral activity of MK-0518, a potent HIV integrase inhibitor
[CHANGES IN THE QUALITATIVE AND QUANTITATIVE COMPOSITION OF GUT MICROBIOTA IN RATS DURING EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS].
Neuroscience. Myelin--more than insulation.
Therapy-related acute leukemia in two patients with multiple sclerosis treated with Mitoxantrone.
A novel anti-EMMPRIN function-blocking antibody reduces T cell proliferation and neurotoxicity: relevance to multiple sclerosis.
Pre-existing T- and B-cell defects in one progressive multifocal leukoencephalopathy patient.
Lack of response to rituximab therapy in patients with neuromyelitis optica: Response to Kim and Kim.
Vitamin D in MS: A vitamin for 4 seasons.
CCSVI is associated with multiple sclerosis.
Alpha-tocopherol and MRI Outcomes in Multiple Sclerosis - Association and Prediction.
Safinamide and flecainide protect axons and reduce microglial activation in models of multiple sclerosis.
Different mechanisms underlying changes in excitability of peripheral nerve sensory and motor axons in multiple sclerosis.
Mesenchymal Stem Cell treatment for autoimmune diseases: a critical review.
Cortico-juxtacortical involvement increases risk of epileptic seizures in multiple sclerosis.
Impact of Pharmacotherapy on Cognitive Dysfunction in Patients with Multiple Sclerosis.
Cerebral venous sinus thrombosis in the patient with multiple sclerosis associated with congenital antithrombin deficiency.
Oral laquinimod in patients with relapsing-remitting multiple sclerosis: 36-week double-blind active extension of the multi-centre, randomized, double-blind, parallel-group placebo-controlled study.
The role of stress-response systems for the pathogenesis and progression of MS.
Resveratrol effects on astrocyte function: Relevance to neurodegenerative diseases.
Large-scale neuronal network dysfunction in multiple sclerosis?: Evidence from resting-state fMRI.
[Oral disease modifying therapy of multiple sclerosis: the current view.]
Fingolimod (Gilenya) licence extended
Blood miRNA expression pattern is a possible risk marker for natalizumab-associated progressive multifocal leukoencephalopathy in multiple sclerosis patients.

Pages